Generics.
May 28, 2012 at 14:34 | Source: Moneycontrol.com
May 23, 2012 at 12:21 | Source: Moneycontrol.com
May 18, 2012 at 15:36 | Source: PTI
May 18, 2012 at 12:58 | Source: Moneycontrol.com
May 18, 2012 at 12:56 | Source: CNBC-TV18
News across the web »
May 28, 2012 at 17:56 | Source: DNA India
May 28, 2012 at 16:36 | Source: DNA India
May 28, 2012 at 02:31 | Source: Business Standard
May 26, 2012 at 00:12 | Source: Market Watch
May 25, 2012 at 16:22 | Source: The Hindu BusinessLine
Interact & exchange stock tips & market info »
Related News »
Back in March, we wrote about an important development in India, where a compulsory license for Bayer's Nexavar anti-cancer drug was granted. Bayer, of course, is fighting back: in its 37-page appeal to the Intellectual Property Appellate Board ...
May 24, 2012 at 02:57 | Source: Tech Dirt
Key facts, issues and questionsWhat branded companies are taking an interest in generics – we identify and assess the latest developments What has Teva been up to in Japan in 2011? Biosimilars get ever closer – latest regulatory data update ...
May 29, 2012 at 12:10 | Source: Yahoo Finance
(Reuters) - Hikma Pharmaceuticals Plc said it expects profitability in its generics business to be hurt by continuing price competition and steps it has taken to comply with a warning letter from U.S. regulators. In February, the company ...
May 17, 2012 at 07:02 | Source: msnbc.com
AUSTIN, Texas, May 22, 2012 /PRNewswire/ -- Prodigy Generics, a division of Prodigy Health Supplier Corporation (PHS), has launched injectable irinotecan. Irinotecan is the generic equivalent of the branded drug Camptosar by Pfizer. Prodigy ...
May 22, 2012 at 19:49 | Source: Genetic Engineering News
Dr. Reddy's Laboratories ( RDY) has been busy launching generics and the recent U.S. launch of a generic version of Novatis AG 's ( NVS) over-the-counter (OTC) drug, Prevacid, was the second one in less than a week. The U.S. Food and Drug ...
May 21, 2012 at 18:31 | Source: NASDAQ
Dr. Reddy’s Laboratories (RDY) reported fiscal 2012 (ended March 31) earnings per American Depositary Share (ADS) of $1.60, above the year-ago earnings of $1.30 per ADS. Higher revenues boosted earnings. The Zacks Consensus Estimate for fiscal ...
May 14, 2012 at 11:59 | Source: Yahoo Finance
(AP) TRENTON, N.J. -Merck & Co. (MRK) CEO Kenneth Frazier told company shareholders on Tuesday that 2012 and 2013 will be difficult years, but he's confident the company can weather them. Speaking at the company's annual meeting, Frazier noted ...
May 22, 2012 at 15:10 | Source: CBS News
Bharatbook from its exhaustive collection has come out with a report "Japan Generics Market Analysis " which gives an overview, Demand, Supply Trends and industry analysis reports. Japan is the world’s second largest pharmaceutical markets in the world ...
May 12, 2012 at 05:13 | Source: PR-USA.net
Over the next 5 years, branded pharmaceutical manufacturers face a period of intense generic competition as numerous branded blockbusters face patent expiry. Consequently, having a clear idea about how to maximize portfolio sales and defend against generic ...
May 15, 2012 at 04:55 | Source: Transworld News
MANILA, Philippines - Asia’s top pharmacy brand, Watsons, recently launched Buy Generics and Save program as part of its massive health campaign. At a media event held at the Stock Market in BGC’s High Street, Watsons also unveiled an extensive range ...
May 23, 2012 at 15:59 | Source: Philippine Star Online